Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1239780 | 0.89 | TLR8 (0.69) | TLR8TLR7 | |
| SCHEMBL22770869 | 0.88 | TLR8 (0.54) | TLR8TLR7 | |
| SCHEMBL28771849 | 0.86 | TLR8 (0.63) | TLR8TLR7 | |
| SCHEMBL22771001 | 0.86 | TLR8 (0.60) | TLR8TLR7 | |
| SCHEMBL27078327 | 0.86 | TLR8 (0.83) | TLR8TLR7 | |
| SCHEMBL23165953 | 0.84 | TLR8 (0.71) | TLR8TLR7 | |
| SCHEMBL29280545 | 0.84 | TLR8 (0.85) | TLR8TLR7 | |
| SCHEMBL22770868 | 0.84 | TLR8 (0.58) | TLR8TLR7 | |
| SCHEMBL29280560 | 0.84 | TLR8 (0.82) | TLR8TLR7 | |
| SCHEMBL28771670 | 0.83 | TLR8 (0.59) | TLR8TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3983082-A1 | AMINOBENZAZEPINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOF | Bolt Biotherapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-3983080-A1 | MACROMOLECULE-SUPPORTED AMINOBENZAZEPINE COMPOUNDS | Bolt Biotherapeutics, Inc. (US) | 2022-04-20 | — | — | EP | disclosed |
| WO-2021067242-A1 | AMIDE-LINKED, AMINOBENZAZEPINE IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2020252254-A1 | MACROMOLECULE-SUPPORTED AMINOBENZAZEPINE COMPOUNDS | BOLT BIOTHERAPEUTICS, INC. (US) | 2020-12-17 | — | — | WO | disclosed |
| WO-2020252294-A1 | AMINOBENZAZEPINE COMPOUNDS, IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. (US) | 2020-12-17 | — | — | WO | disclosed |